HealthDay News

HealthDay News is a content partner with GU Oncology Now.

Articles by HealthDay News

HealthDay NewsRLT | September 20, 2022
Both imaging diagnostics are accurate for detecting lymph node involvement in prostate cancer.
Read More
HealthDay NewsRLT | September 20, 2022
The incidence was seen with the use of 18F-fluorocholine PET/CT and 68Ga-PSMA-11 PET/CT.
HealthDay NewsRLT | July 5, 2022
Implementing molecular imaging into focal dose radiation is feasible in intermediate-, high-risk prostate cancer patients.
HealthDay NewsRLT | July 5, 2022
None of the investigated imaging parameters significantly outperformed maximum standardized uptake value.
HealthDay NewsRLT | June 21, 2022
An analysis of recurrence patterns on PET after sRT showed abdominal-lymphatic and distant metastatic patterns.
HealthDay NewsRLT | June 21, 2022
miPSMA expression score was higher for 18F-PSMA-11 than 68Ga-PSMA-11.
HealthDay NewsRLT | February 5, 2024
Diagnostic accuracy is significantly better for baseline imaging than for images obtained after systemic therapy.
HealthDay NewsRLT | May 24, 2022
PSMA PET and high EAU risk are linked to worse event-free survival in patients who received salvage radiation treatment.
HealthDay NewsRLT | May 24, 2022
68Ga-PSMA-11 PET/CT detects bone metastases in 22.3% of patients with negative 99mTc-MDP BS results, study finds.
HealthDay NewsRLT | May 24, 2022
RECIP 1.0, incorporating PSMA PET/CT, can assess tumor response early in course of 177Lu-PSMA therapy.
HealthDay NewsRLT | May 24, 2022
Best model based on [68Ga]Ga-PSMA-11 PET had prediction efficiency of 95% in training phase, 100% in test phase.
HealthDay NewsRLT | September 20, 2022
PSMA PET/CT for biochemical recurrence performed prior to SRT linked to improved outcomes for patients with prostate cancer.
HealthDay NewsRLT | September 20, 2022
PSMA-PET/CT findings affect treatment decisions and selection of radiation therapy in the management of prostate cancer.
HealthDay NewsRLT | September 20, 2022
⁶⁸Ga-PSMA PET/CT has promising diagnostic accuracy for lymph node staging before radical prostatectomy, study shows.
HealthDay NewsRLT | September 20, 2022
⁶⁸Ga-PSMA PET/CT improves detection of high-risk prostate cancer compared with multiparametric magnetic resonance ...
HealthDay NewsProstate Cancer | January 19, 2022
Newer forms of hormone therapy are effective at keeping prostate cancer in check but also can increase risk of depression.
HealthDay NewsProstate Cancer | September 19, 2022
Analysis shows that radiation therapy seems to work better for Black men with prostate cancer than for their White peers.
HealthDay NewsProstate Cancer | September 19, 2022
Unemployment is adversely linked to recommended cancer screening, and the link is explained by lack of health insurance.
HealthDay NewsRLT | September 20, 2022
Men with high risk BCR according to EAU Prostate Cancer Guidelines Panel and BCP have higher rates of metastatic disease.
HealthDay NewsRLT | September 20, 2022
The results are promising in comparison to other studies.